Results 181 to 190 of about 521,761 (340)

Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real‐World Evidence

open access: yesAnnals of Neurology, EarlyView.
Objective The objective of this study was to compare the long‐term safety profiles of ocrelizumab and rituximab in persons with multiple sclerosis (MS). Methods Using retrospective data from the University of California (UC) Health System, we simulated a target clinical trial. The primary cohort from UC San Francisco (UCSF) and a validation cohort from
Gabriel Cerono   +3 more
wiley   +1 more source

Use of ambulatory pathways in emergency general surgery: a systematic review. [PDF]

open access: yesBMJ Open
Fox B   +4 more
europepmc   +1 more source

EVALUATION OF ARRHYTHMIAS IN CHILDREN. EXERCISE TESTING VS. AMBULATORY MONITORING [PDF]

open access: bronze, 1977
John J. Rozanski   +5 more
openalex   +1 more source

From Diagnosis to Disease Staging: Multisite Validation of Cerebrospinal Fluid Molecular Tests in Multiple Sclerosis

open access: yesAnnals of Neurology, EarlyView.
Objective The growing demand for personalized treatment in multiple sclerosis (MS) highlights the need for more precise biomarkers that can outperform magnetic resonance imaging and clinical assessment in patient stratification. Advances in multiplex proteomic technologies suggest that cerebrospinal fluid (CSF) analysis at MS onset may not only improve
Laura Ghezzi   +10 more
wiley   +1 more source

Prognostic Significance of 24-Hour Ambulatory Blood Pressure and Holter Monitoring in Patients without Atrial Fibrillation

open access: yesThe Ewha Medical Journal, 2023
Sojeong Park   +4 more
doaj   +1 more source

Multiplexed Cutaneous Wound Monitor for Point‐of‐Care Applications

open access: yesAdvanced NanoBiomed Research, EarlyView.
Wearable monitors are poised to transform wound care, easing healthcare burdens. These devices integrate sensors and wireless capabilities, enabling continuous, remote monitoring. This work showcases a flexible, wireless system‐on‐chip that tracks C‐reactive protein (CRP), interleukin‐6 (IL‐6), pH, and temperature.
Peter Francis Mathew Elango   +10 more
wiley   +1 more source

Expert Perspective: Diagnosis and Treatment of Castleman Disease

open access: yesArthritis &Rheumatology, EarlyView.
Castleman disease (CD) is a major diagnostic challenge for rheumatologists. Unicentric CD (UCD) involves one enlarged lymph node region, whereas multicentric CD (MCD) involves multiple enlarged lymph node regions. Both UCD and MCD may exhibit a wide range of symptoms that overlap with other immune‐mediated conditions.
Luke Y. C. Chen   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy